Krom Pikonilat Alımından Kaynaklanan Karaciğer Toksitesi

Baltacı D; Adem Karaca; Mehmet Soytürk; Meltem Seymen; Mehmet Halis Tanrıverdi

Krom Pikonilat Alımından Kaynaklanan Karaciğer Toksitesi

Yıl 2010, Cilt: 2 Sayı: 1, 32 - 34, 01.04.2010

Baltacı D Adem Karaca Mehmet Soytürk Meltem Seymen Mehmet Halis Tanrıverdi

Anahtar Kelimeler

Krom Pikolinat, Karaciğer Toksisitesi, Reçetesiz ilaç, Kaşıntı

Kaynakça

1. Ghosh D, Bhattacharya B, Mukherjee B et al. Role of chromium supplementation in Indians with type 2 diabetes mellitus. Nutr Biochem 2002;13(11):690-697.
2. Berner TO, Murphy MM, Slesinski R. Determining the safety of chromium tripicolinate for addition to foods as a nutrient supplement. Food Chem Toxicol 2004;42(6):1029-1042.
3. Anderson RA, Polansky MM, Bryden NA et al. Chromium supplementation of human subjects: effects on glucose, insulin, and lipid variables. Metabolism 1983;32:894-899.
4. Jeejeebhoy KN. The role of chromium in nutrition and therapeutics and as a potential toxin. Nutr Rev 1999;57(11):329-335.
5. Vincent JB. The potential value and toxicity of chromium picolinate as a nutritional supplement, weight loss agent and muscle development agent. Sports Med 2003;33(3):213-230.
6. Broadhurst CL, Domenico P. Clinical studies on chromium picolinate supplementation in diabetes mellitus- a review. Diabetes Technol Ther 2006;8(6):677-687.
7. Lamson DS, Steven MP. The safety and efficacy of high-dose chromium. Altern Med Rev 2002;7(3):218- 235.
8. Bagchi D, Stohs SJ, Downs BW, Bagchi M, Preuss HG. Cytotoxicity and oxidative mechanisms of different forms of chromium. Toxicology. 2002;180(1):5-22.
9. Press RI, Geller J, Evans GW. The effect of chromium picolinate on serum cholesterol and apolipoprotein fractions in human subjects. West J Med 1990;152: 41-45.
10. Martin WR, Fuller RE. Suspected chromium picolinate-induced rhabdomyolysis. Pharmacotherapy 1998;18:860-862.
11. Wasser WG, Feldman NS, DíAgati VD. Chronic renal failure after ingestion of over-the-counter chromium picolinate. Ann Intern Med 1997;126:410.
12. Cerulli J, Grabe DW, Gauthier I et al. Chromium picolinate toxicity. Ann Pharmacother 1998;32:428-431.

Yıl 2010, Cilt: 2 Sayı: 1, 32 - 34, 01.04.2010

Baltacı D Adem Karaca Mehmet Soytürk Meltem Seymen Mehmet Halis Tanrıverdi

Kaynakça

1. Ghosh D, Bhattacharya B, Mukherjee B et al. Role of chromium supplementation in Indians with type 2 diabetes mellitus. Nutr Biochem 2002;13(11):690-697.
2. Berner TO, Murphy MM, Slesinski R. Determining the safety of chromium tripicolinate for addition to foods as a nutrient supplement. Food Chem Toxicol 2004;42(6):1029-1042.
3. Anderson RA, Polansky MM, Bryden NA et al. Chromium supplementation of human subjects: effects on glucose, insulin, and lipid variables. Metabolism 1983;32:894-899.
4. Jeejeebhoy KN. The role of chromium in nutrition and therapeutics and as a potential toxin. Nutr Rev 1999;57(11):329-335.
5. Vincent JB. The potential value and toxicity of chromium picolinate as a nutritional supplement, weight loss agent and muscle development agent. Sports Med 2003;33(3):213-230.
6. Broadhurst CL, Domenico P. Clinical studies on chromium picolinate supplementation in diabetes mellitus- a review. Diabetes Technol Ther 2006;8(6):677-687.
7. Lamson DS, Steven MP. The safety and efficacy of high-dose chromium. Altern Med Rev 2002;7(3):218- 235.
8. Bagchi D, Stohs SJ, Downs BW, Bagchi M, Preuss HG. Cytotoxicity and oxidative mechanisms of different forms of chromium. Toxicology. 2002;180(1):5-22.
9. Press RI, Geller J, Evans GW. The effect of chromium picolinate on serum cholesterol and apolipoprotein fractions in human subjects. West J Med 1990;152: 41-45.
10. Martin WR, Fuller RE. Suspected chromium picolinate-induced rhabdomyolysis. Pharmacotherapy 1998;18:860-862.
11. Wasser WG, Feldman NS, DíAgati VD. Chronic renal failure after ingestion of over-the-counter chromium picolinate. Ann Intern Med 1997;126:410.
12. Cerulli J, Grabe DW, Gauthier I et al. Chromium picolinate toxicity. Ann Pharmacother 1998;32:428-431.

Toplam 12 adet kaynakça vardır.

Ayrıntılar

Birincil Dil	Türkçe
Bölüm	Makaleler
Yazarlar	Baltacı D Bu kişi benim Adem Karaca Bu kişi benim Mehmet Soytürk Bu kişi benim Meltem Seymen Bu kişi benim Mehmet Halis Tanrıverdi Bu kişi benim
Yayımlanma Tarihi	1 Nisan 2010
Yayımlandığı Sayı	Yıl 2010 Cilt: 2 Sayı: 1

Kaynak Göster

APA	D, B., Karaca, A., Soytürk, M., Seymen, M., vd. (2010). Krom Pikonilat Alımından Kaynaklanan Karaciğer Toksitesi. Konuralp Medical Journal, 2(1), 32-34.
AMA	D B, Karaca A, Soytürk M, Seymen M, Tanrıverdi MH. Krom Pikonilat Alımından Kaynaklanan Karaciğer Toksitesi. Konuralp Medical Journal. Nisan 2010;2(1):32-34.
Chicago	D, Baltacı, Adem Karaca, Mehmet Soytürk, Meltem Seymen, ve Mehmet Halis Tanrıverdi. “Krom Pikonilat Alımından Kaynaklanan Karaciğer Toksitesi”. Konuralp Medical Journal 2, sy. 1 (Nisan 2010): 32-34.
EndNote	D B, Karaca A, Soytürk M, Seymen M, Tanrıverdi MH (01 Nisan 2010) Krom Pikonilat Alımından Kaynaklanan Karaciğer Toksitesi. Konuralp Medical Journal 2 1 32–34.
IEEE	B. D, A. Karaca, M. Soytürk, M. Seymen, ve M. H. Tanrıverdi, “Krom Pikonilat Alımından Kaynaklanan Karaciğer Toksitesi”, Konuralp Medical Journal, c. 2, sy. 1, ss. 32–34, 2010.
ISNAD	D, Baltacı vd. “Krom Pikonilat Alımından Kaynaklanan Karaciğer Toksitesi”. Konuralp Medical Journal 2/1 (Nisan 2010), 32-34.
JAMA	D B, Karaca A, Soytürk M, Seymen M, Tanrıverdi MH. Krom Pikonilat Alımından Kaynaklanan Karaciğer Toksitesi. Konuralp Medical Journal. 2010;2:32–34.
MLA	D, Baltacı vd. “Krom Pikonilat Alımından Kaynaklanan Karaciğer Toksitesi”. Konuralp Medical Journal, c. 2, sy. 1, 2010, ss. 32-34.
Vancouver	D B, Karaca A, Soytürk M, Seymen M, Tanrıverdi MH. Krom Pikonilat Alımından Kaynaklanan Karaciğer Toksitesi. Konuralp Medical Journal. 2010;2(1):32-4.